Stockscreener 앱 받기
12.03
1.73%
0.1831
전일 마감가:
$11.85
열려 있는:
$11.92
하루 거래량:
568.21K
Relative Volume:
0.18
시가총액:
$1.56B
수익:
$628.25M
순이익/손실:
$-78.55M
주가수익비율:
-19.41
EPS:
-0.62
순현금흐름:
$-29.73M
1주 성능:
+2.95%
1개월 성능:
+16.59%
6개월 성능:
+70.51%
1년 성능:
-32.01%
1일 변동 폭
$11.77
$12.10
1주일 범위
$11.62
$12.20
52주 변동 폭
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
명칭
Neogenomics Inc
전화
(239) 768-0600
주소
9490 NEOGENOMICS WAY, FORT MYERS, FL
NEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
12.04 | 1.53B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
571.33 | 215.01B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.00 | 159.87B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
699.27 | 56.23B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
140.05 | 39.54B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.28 | 37.85B | 15.90B | 1.28B | 2.21B | 7.2842 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-29 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 개시 | Guggenheim | Neutral |
| 2025-04-30 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 개시 | Jefferies | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-08-21 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-02-24 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-02-01 | 업그레이드 | Needham | Hold → Buy |
| 2022-08-26 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-22 | 다운그레이드 | Needham | Buy → Hold |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-03-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-29 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 재개 | Stephens | Overweight |
| 2021-12-16 | 개시 | Cowen | Outperform |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-25 | 재개 | Needham | Buy |
| 2021-02-25 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-12-11 | 재개 | BTIG Research | Buy |
| 2020-10-28 | 재확인 | Needham | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-08-28 | 개시 | Guggenheim | Buy |
| 2020-07-29 | 재확인 | Needham | Buy |
| 2020-06-25 | 개시 | BofA/Merrill | Buy |
| 2020-04-21 | 재개 | Stephens | Overweight |
| 2020-03-02 | 재개 | Craig Hallum | Buy |
| 2020-02-28 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-01 | 재확인 | Needham | Buy |
| 2019-03-29 | 재확인 | Needham | Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-10-24 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 개시 | Leerink Partners | Outperform |
| 2018-05-02 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-08-24 | 개시 | Gabelli & Co | Buy |
| 2016-12-15 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Neogenomics Inc 주식(NEO)의 최신 뉴스
Natera dismisses appeal in patent case against NeoGenomics - Investing.com India
Natera dismisses appeal in patent case against NeoGenomics By Investing.com - Investing.com Australia
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litig - pharmiweb.com
NeoGenomics Says Natera Withdraws Appeal in Patent Case - marketscreener.com
Neogenomics announces that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation - marketscreener.com
Neogenomics Announces That Natera Has Voluntarily Withdrawn Its Appeal In Ongoing RaDaR Patent Litigation - TradingView — Track All Markets
NeoGenomics, Inc. $NEO Shares Acquired by Squarepoint Ops LLC - MarketBeat
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation - Business Wire
Value Recap: Will NeoGenomics Inc NG9 stock outperform foreign stocksJuly 2025 Retail & AI Enhanced Execution Alerts - moha.gov.vn
US Market Wrap: Why NeoGenomics Inc stock is trending among retail tradersJuly 2025 Summary & Safe Entry Point Identification - moha.gov.vn
Bellevue Group AG Reduces Stake in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics Inc Stock Analysis and ForecastTake Profit Strategies & Start Your Free Trading Journey Today - earlytimes.in
What analysts say about The Hershey Company stockShort Interest Overview & Free Long-Term Investment Planning - earlytimes.in
The Supreme Industries Limited (SUPREMEIND) Announces Strategic ShiftValue Traps to Avoid & Get Ahead with Our Profit-Packed Picks - earlytimes.in
Will New RaDaR MRD Data and Myeloid Profiling Advances Change NeoGenomics' (NEO) Diagnostics Narrative? - simplywall.st
NeoGenomics to Present New ctDNA Research at SABCS 2025 - BioSpace
NeoGenomics (NEO): Assessing Valuation After a 44% Three-Month Share Price Rebound - Yahoo Finance
Quantbot Technologies LP Buys New Holdings in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025 - BioSpace
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies a - pharmiweb.com
Risk Hedge: Can NeoGenomics Inc NG9 stock sustain margin levelsJuly 2025 Fed Impact & Verified Short-Term Plans - moha.gov.vn
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) - The Globe and Mail
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study - Nature
Is NeoGenomics Inc. (NG9) stock attractive for growth fundsWeekly Volume Report & Accurate Entry and Exit Point Alerts - Newser
How NeoGenomics Inc. stock benefits from tech adoptionJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Will NeoGenomics Inc. (NG9) stock announce a stock splitGlobal Markets & Free High Return Stock Watch Alerts - Newser
Greenhouse Funds LLLP Boosts Stock Holdings in NeoGenomics, Inc. $NEO - MarketBeat
Can NeoGenomics Inc. (NG9) stock deliver double digit returnsNew Guidance & Expert Approved Momentum Trade Ideas - Newser
NeoGenomics, Inc. $NEO Shares Bought by Samjo Management LLC - MarketBeat
Will NeoGenomics Inc. (NG9) stock announce special dividendOil Prices & Technical Confirmation Trade Alerts - Newser
Is NeoGenomics Inc. (NG9) stock supported by free cash flowWeekly Trend Report & Risk Adjusted Swing Trade Ideas - Newser
Can NeoGenomics Inc. (NG9) stock survive global slowdownMarket Risk Summary & Daily Entry Point Trade Alerts - Newser
Geode Capital Management LLC Buys 26,224 Shares of NeoGenomics, Inc. $NEO - MarketBeat
American Century Companies Inc. Has $25.71 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Ideas Watch: How rising interest rates impact NeoGenomics Inc. stockJuly 2025 Gainers & Reliable Volume Spike Alerts - BỘ NỘI VỤ
Insider Selling: NeoGenomics (NASDAQ:NEO) EVP Sells 20,916 Shares of Stock - MarketBeat
Neogenomics EVP Olivo sells $250k in NEO stock By Investing.com - Investing.com Canada
Neogenomics EVP Olivo sells $250k in NEO stock - Investing.com India
NEOGENOMICS EVP Alicia C Olivo Sells Shares - TradingView
Is NeoGenomics Inc a good long term investmentMarket Breadth Indicators & Access Insider-Level Stock Analysis - earlytimes.in
What analysts say about NeoGenomics Inc stockDividend Aristocrats List & Free Professional Investment Consultations - earlytimes.in
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
NeoGenomics Reports Strong Revenue Growth Amid Rising Losses - MSN
NeoGenomics Inc (NG9.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know - TradingView
First Week of January 2026 Options Trading For NeoGenomics (NEO) - Nasdaq
How NeoGenomics Inc. stock compares to market leadersWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Can NeoGenomics Inc. (NG9) stock sustain revenue momentumJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
How hedge fund analytics apply to NeoGenomics Inc. stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Is NeoGenomics Inc. stock a buy on dipsLayoff News & Smart Swing Trading Techniques - newser.com
Neogenomics Inc (NEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
0.75%
자본화:
|
볼륨(24시간):